Home Cart Sign in  
Chemical Structure| 111664-82-5 Chemical Structure| 111664-82-5

Structure of Dehydroevodiamine HCl
CAS No.: 111664-82-5

Chemical Structure| 111664-82-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dehydroevodiamine HCl is an alkaloid isolated from E. rutaecarpa and possesses anti-inflammatory, antiarrhythmic, hypotensive, and anti-amnesic biological activities.

Synonyms: Dehydroevodiamine (hydrochloride); Dehydroevodiamine hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dehydroevodiamine HCl

CAS No. :111664-82-5
Formula : C19H16ClN3O
M.W : 337.80
SMILES Code : O=C1N2C(N(C)C3=C1C=CC=C3)=C4C(CC2)=C5C=CC=CC5=N4.[H]Cl
Synonyms :
Dehydroevodiamine (hydrochloride); Dehydroevodiamine hydrochloride
MDL No. :MFCD32061978

Safety of Dehydroevodiamine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Dehydroevodiamine HCl

pyroptosis

Isoform Comparison

Biological Activity

Target
  • AChE

In Vitro:

Cell Line
Concentration Treated Time Description References
Hepa-1c1c7 cells 5 μM 12 h Luciferase reporter gene assays confirmed the ability of RUT, EOD, and DHED to activate AHR, showing that at 5 μM, RUT, EOD, and DHED induced luciferase activity by 23.6-, 2.14-, and 10.8-fold, respectively Drug Metab Dispos. 2018 Jul;46(7):1030-1040
HepG2 cells 5 μM 12 h Luciferase reporter gene assays confirmed the ability of RUT, EOD, and DHED to activate AHR, showing that at 5 μM, RUT, EOD, and DHED induced luciferase activity by 20.4-, 2.43-, and 6.60-fold, respectively Drug Metab Dispos. 2018 Jul;46(7):1030-1040
mouse primary hepatocytes 5 μM 24 h To investigate whether RUT, EOD, and DHED could directly activate the AHR, results showed that Cyp1a1 mRNA was significantly upregulated, with RUT, EOD, and DHED inducing 665-, 12.5-, and 20.6-fold, respectively, with an efficacy order of RUT > DHED > EOD Drug Metab Dispos. 2018 Jul;46(7):1030-1040

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6N mice Wild-type and Ahr-/- mice Oral gavage 80 mg/kg Once daily for 3, 12, and 21 days To determine the in vivo AHR-activating effects of RUT, EOD, and DHED, results showed that RUT and DHED markedly upregulated hepatic AHR target gene expression in wild-type mice but not in Ahr-/- mice; EOD failed to activate AHR in vivo Drug Metab Dispos. 2018 Jul;46(7):1030-1040
SD rats DSS-induced ulcerative colitis model Gavage 20 mg/kg and 40 mg/kg 7 consecutive days Significantly alleviated DSS-induced colitis symptoms, suppressed inflammatory and oxidative stress responses, repaired colonic barrier injury, and inhibited apoptosis Molecules. 2024 Aug 26;29(17):4031

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.80mL

2.96mL

1.48mL

29.60mL

5.92mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories